Offstream
news

Mexican health regulator COFEPRIS approves the emergency use of Pfizer's anti-COVID-19 oral drug Paxlovid.
2022-01-14

The final results of a trial of Paxlovid conducted by Pfizer shows 89% cut of risk of hospitalization and death in high-risk patients and is likely to work against the Omicron variant.
2021-12-14

The British government signs an agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator.
2021-10-20

Pfizer says that they plan to develop new vaccines for other viruses following the success of their COVID-19 vaccine candidate.
2021-03-23

Oman officially begins a vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine. The country is the last Gulf Cooperation Council member state to begin vaccinations. Health Minister Ahmed Al-Saidi is one of the first citizens to receive a dose of the vaccine.
2020-12-27

Serbia officially begins its vaccination programme against COVID-19, with Prime Minister Ana Brnabić becoming the first person to receive the Pfizer-BioNTech vaccine.
2020-12-24

Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine.
2020-12-13

Officials from The Pentagon say that they will receive 44,000 doses of the Pfizer-BioNTech's Tozinameran vaccine. However, it will not be mandatory for soldiers to receive the vaccine.
2020-12-9

The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week.
2020-12-2

Pfizer CEO Albert Bourla says that the vaccine trials for Pfizer might have results by October.
2020-09-3